港股市場個股詳情

06660 艾美疫苗

添加自選

8.720
+0.280+3.32%

已收盤 05/02 16:08 (北京)

105.60億總市值-7358市盈率TTM

艾美疫苗股票討論區

登錄發表評論

Moomoo AI

2023/12/02 08:42

The high level of insider ownership and willingness to buy shares at prices exceeding current market indicate a bullish outlook for AIM Vaccine. The recent loss did not dampen their enthusiasm, identifying it as a potential watchlist candidate for investors.

AIM Vaccine Insider Ups Holding By 649% During Year

Moomoo AI

2023/10/24 08:56

艾美疫苗的回購顯示出管理層對未來發展的信心。醫藥行業將迎來新景氣度上升週期，作爲全鏈疫苗集團，艾美疫苗的價值顯現。重磅產品如13價結合肺炎疫苗將助其業績開闢更大想象空間。艾美疫苗深厚研發底蘊與產品升級，加管理層回購及新品種進展，預示其股價有大幅上升空間。

已翻譯

從股票回購到研發佈局，解讀艾美疫苗(06660)被低估的成長潛力

Steven000

2023/03/27 13:01

$艾美疫苗(06660.HK)$
圓弧底形態，5日均線上穿10日均線，MACD水上金叉，短線依舊看漲，注意後期MACD出現頂背離的風險，控制倉位，快進快出。

已翻譯

Spinee

2022/12/14 14:12

The domestic COVID-19 oral drug Azifodine is planned to be sold online, and $復星醫藥(02196.HK)$ shares were opened 12% higher to 29 yuan.
$輝瑞(PFE.US)$$艾美疫苗(06660.HK)$